We further studied the relationships between patient age, tumor size, histological grade, histological type, molecular type, cancer stem cell (CSC) ratio, galectin-3 expression, and chemotherapeutic sensitivity in 135 breast cancer cases involving neoadjuvant chemotherapy. This evidence concerns the gene LGALS3 and neoplasm.